These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19270513)

  • 1. Malignant stem cells in childhood acute lymphoblastic leukemia: the stem cell concept revisited.
    Vormoor HJ
    Cell Cycle; 2009 Apr; 8(7):996-9. PubMed ID: 19270513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
    le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
    Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia.
    Baersch G; Baumann M; Ritter J; Jürgens H; Vormoor J
    Br J Haematol; 1999 Dec; 107(3):572-80. PubMed ID: 10583262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
    Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
    Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
    Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD133 on leukemia-initiating cells in childhood ALL.
    Cox CV; Diamanti P; Evely RS; Kearns PR; Blair A
    Blood; 2009 Apr; 113(14):3287-96. PubMed ID: 19147788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.
    Wilson K; Case M; Minto L; Bailey S; Bown N; Jesson J; Lawson S; Vormoor J; Irving J
    Haematologica; 2010 Apr; 95(4):679-83. PubMed ID: 19951974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia.
    Johnson SM; Dempsey C; Chadwick A; Harrison S; Liu J; Di Y; McGinn OJ; Fiorillo M; Sotgia F; Lisanti MP; Parihar M; Krishnan S; Saha V
    Blood; 2016 Jul; 128(3):453-6. PubMed ID: 27099150
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequencies of immature CD34 + CD38 - and CD34 + CD38-CD19 + blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia.
    Shman TV; Movchan LV; Aleinikova OV
    Leuk Lymphoma; 2013 Nov; 54(11):2560-2. PubMed ID: 23432723
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.
    Cui W; Kong NR; Ma Y; Amin HM; Lai R; Chai L
    Mod Pathol; 2006 Dec; 19(12):1585-92. PubMed ID: 16998462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia.
    Hauer J; Mullighan C; Morillon E; Wang G; Bruneau J; Brousse N; Lelorc'h M; Romana S; Boudil A; Tiedau D; Kracker S; Bushmann FD; Borkhardt A; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Blood; 2011 Jul; 118(3):544-53. PubMed ID: 21622646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection.
    Burnusuzov HA; Spasova MI; Murdjeva MA; Stoyanova AA; Mumdziev IN; Kaleva VI; Belcheva MI; Bosheva MN
    Folia Med (Plovdiv); 2016 Mar; 58(1):28-35. PubMed ID: 27383875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations.
    Rehe K; Wilson K; Bomken S; Williamson D; Irving J; den Boer ML; Stanulla M; Schrappe M; Hall AG; Heidenreich O; Vormoor J
    EMBO Mol Med; 2013 Jan; 5(1):38-51. PubMed ID: 23229821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.
    Ruella M; Barrett DM; Kenderian SS; Shestova O; Hofmann TJ; Perazzelli J; Klichinsky M; Aikawa V; Nazimuddin F; Kozlowski M; Scholler J; Lacey SF; Melenhorst JJ; Morrissette JJ; Christian DA; Hunter CA; Kalos M; Porter DL; June CH; Grupp SA; Gill S
    J Clin Invest; 2016 Oct; 126(10):3814-3826. PubMed ID: 27571406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of acute lymphoblastic leukemia progenitor cells.
    Cox CV; Evely RS; Oakhill A; Pamphilon DH; Goulden NJ; Blair A
    Blood; 2004 Nov; 104(9):2919-25. PubMed ID: 15242869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric identification of candidate normal stem cell populations in CD45-negative B-cell precursor acute lymphoblastic leukaemia.
    Vormoor J; Baersch G; Baumann M; Ritter J; Jürgens H
    Br J Haematol; 1998 Mar; 100(3):501-8. PubMed ID: 9504632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant stem cells in childhood ALL: the debate continues!
    Heidenreich O; Vormoor J
    Blood; 2009 Apr; 113(18):4476-7; author reply 4477. PubMed ID: 19407001
    [No Abstract]   [Full Text] [Related]  

  • 20. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
    Geron I; Savino AM; Fishman H; Tal N; Brown J; Turati VA; James C; Sarno J; Hameiri-Grossman M; Lee YN; Rein A; Maniriho H; Birger Y; Zemlyansky A; Muler I; Davis KL; Marcu-Malina V; Mattson N; Parnas O; Wagener R; Fischer U; Barata JT; Jamieson CHM; Müschen M; Chen CW; Borkhardt A; Kirsch IR; Nagler A; Enver T; Izraeli S
    Nat Commun; 2022 Feb; 13(1):659. PubMed ID: 35115489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.